Marshall Wace North America’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-380,959
| Closed | -$5.53M | – | 1448 |
|
|
2018
Q3 | $5.53M | Sell |
380,959
-150,251
| -28% | -$2.18M | 0.04% | 295 |
|
|
2018
Q2 | $10.6M | Sell |
531,210
-155,381
| -23% | -$3.1M | 0.06% | 320 |
|
|
2018
Q1 | $12M | Sell |
686,591
-47,725
| -6% | -$836K | 0.06% | 355 |
|
|
2017
Q4 | $18.1M | Sell |
734,316
-80,289
| -10% | -$1.98M | 0.1% | 250 |
|
|
2017
Q3 | $21.2M | Sell |
814,605
-67,692
| -8% | -$1.76M | 0.13% | 202 |
|
|
2017
Q2 | $23.8M | Buy |
882,297
+178,436
| +25% | +$4.82M | 0.17% | 150 |
|
|
2017
Q1 | $21.1M | Buy |
+703,861
| New | +$21.1M | 0.17% | 172 |
|